PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
11867198-2	2002	Idarubicin (4-demethoxydaunorubicin; Ida), a semisynthetic derivative of daunorubicin (Dnr) is more potent than the parent compound in vitro and in vivo.	Daunorubicin	23-35	alpha-L-iduronidase	Homo sapiens	0-3	
14701777-1	2004	PURPOSE: Randomized comparisons of idarubicin (IDA) with daunorubicin (DNR) show that in adults with acute myeloid leukemia (AML), IDA achieves higher remission rates and longer remission durations.	Daunorubicin	57-69	alpha-L-iduronidase	Homo sapiens	131-134	
11867198-2	2002	Idarubicin (4-demethoxydaunorubicin; Ida), a semisynthetic derivative of daunorubicin (Dnr) is more potent than the parent compound in vitro and in vivo.	Daunorubicin	87-90	alpha-L-iduronidase	Homo sapiens	0-3